Prelude Capital Management’s Precigen PGEN Stock Holding History

Prelude Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.03M	Sell	882,267 -387,786	-31%	-$1.68M	0.37%	53
2026 Q1	$4.92M	Buy	1,270,053 +620,079	+95%	+$2.54M	0.38%	52
2025 Q4	$2.72M	Buy	649,974 +380,463	+141%	+$1.47M	0.2%	110
2025 Q3	$887K	Buy	269,511 +138,421	+106%	+$391K	0.07%	334
2025 Q2	$186K	Buy	+131,090	New	+$186K	0.02%	834
2024 Q1	–	Sell	-16,393	Closed	-$22K	–	1484
2023 Q4	$22K	Buy	+16,393	New	+$19.3K	﹤0.01%	1093
2017 Q3	–	Sell	-6,737	Closed	-$162K	–	1839
2017 Q2	$162K	Buy	+6,737	New	+$148K	0.02%	644
2014 Q4	–	Sell	-3,000	Closed	-$53K	–	2107
2014 Q3	$53K	Hold	3,000	–	–	0.01%	1378
2014 Q2	$72K	Hold	3,000	–	–	0.01%	1236
2014 Q1	$75K	Buy	3,000 +2,956	+6,718%	+$81.8K	0.01%	1141
2013 Q4	$1K	Buy	+44	New	+$889	﹤0.01%	1577

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prelude Capital Management's PGEN Position: Q2 2026 in Review

Prelude Capital Management reduced its Precigen (PGEN) stake by 31% in Q2 2026, selling an estimated $1.68M and leaving 882,267 shares worth $5.03M. The position accounts for 0.37% of the portfolio, ranked #53.

Prelude Capital Management first reported a position in PGEN in Q4 2013 and has held it in 11 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Prelude Capital Management held 882,267 shares of Precigen worth $5.03M as of Q2 2026.
Prelude Capital Management sold 387,786 Precigen shares in Q2 2026, an estimated $1.68M.
Precigen made up 0.37% of Prelude Capital Management's portfolio in Q2 2026, its #53 holding.
Prelude Capital Management first reported a position in Precigen in Q4 2013 and has held it in 11 quarters since.
211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.